Clinical Trial of OPB-111077 in Patients With Relapsed or Refractory Acute Myeloid Leukaemia
NCT03197714
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
9
Enrollment
OTHER
Sponsor class
Conditions
Acute Myeloid Leukemia
Interventions
DRUG:
OPB-111077
Sponsor
Hospital Universitario 12 de Octubre
Collaborators
[object Object]
[object Object]
[object Object]